Summary
We evaluated the metabolism of exogenous arachidonic acid in polymorphonuclear leukocytes from psoriatic patients in comparison with those from normal subjects. The leukocytes were incubated with 10 ΜM labelled arachidonic acid and 5 ΜM A23187 for varying periods of time. We evaluated all the compounds derived from the 5-lipoxygenase activity, including the products of non-enzymatic transformation of leukotriene A4 and w-oxidized leukotriene B4. In the experimental conditions used, there was no significant difference in the formation of any compound at any time of incubation. These results indicate that there is no intrinsic alteration either in 5-lipoxygenase activity or in w-oxidation ability of circulating polymorphonuclear leukocytes in psoriatic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barr R, Wong E, Mallet A, Olins L, Greaves M (1984) The analysis of AA metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins 28:57–65
Brain S, Camp R, Dowd P, Black AK, Greaves M (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of the patients of psoriasis. J Invest Dermatol 83:70–73
Duell EA, Ellis CN, Voorhees JJ (1988) Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin. J Invest Dermatol 91:446–450
Grabbe J, Czarnetzki BM, Rosenbach T, Mardin M (1984) Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol 82:477–479
Hammarström S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified AA, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130–5134
Hammarström S, Lindgren JA, Marcelo CL, Duell EA, Anderson TF, Voorhees J (1979) AA transformations in normal and psoriatic skin. J Invest Dermatol 73:180–183
Kragballe K, Desjarlais L, Duell EA, Voorhees JJ (1986) In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis. J Invest Dermatol 87:47–52
Maurice PDL, Allen BR, Heptinstall S, Bather PC (1986) AA metabolism by peripheral blood cells in psoriasis. Br J Dermatol 114:553–566
Maurice PDL, Bather PC, Allen BR (1986) AA metabolism by polymorphonuclear leukocytes in psoriasis. Br J Dermatol 114:57–64
Maurice PDL, Camp RDR, Allen BR (1987) The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis. Prostaglandins 33:807–818
Powell WS (1984) Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem 259:3082–3089
Ruzicka T, Radspieler H, Strasser T, Przybilla B, Ring J (1985) Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis. Prostaglandins Leukot Med 18:313–319
Ruzicka T, Simmet T, Peskar B, Ring J (1986) Skin levels of AA-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 86:105–108
Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–574
Stüning M, Schultz-Ehrenburg U, Altmeyer P, Raulf M, König W (1987) Metabolism of (14C)arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis. Br J Dermatol 116:153–159
Wróblewski F, LaDue J (1955) Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90:210–213
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solá, J., Vila, L., Puig, L. et al. Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients. Arch Dermatol Res 283, 77–80 (1991). https://doi.org/10.1007/BF00371612
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00371612